Tracy Nogle, DO
Sports Medicine · Orlando, FLNPI 1831625805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $855 and has fallen 84.1% since, to $136 in 2024. That places this record below the midpoint for sports medicine clinicians in FL, where the typical reported total is $1,516.
Across 110 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$411
- Lilly USA, LLC$320
- AstraZeneca$154
- Pfizer$154
- GSK$127
- AbbVie$123
- plus $674 from 20 others
What the payments were for
- Food & beverage$1,95099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $411 |
| Lilly USA, LLC | 19 | $320 |
| AstraZeneca | 8 | $154 |
| Pfizer | 8 | $154 |
| GSK | 7 | $127 |
| AbbVie(2 entities) | 7 | $123 |
| Abbott | 6 | $118 |
| Dynavax Technologies Corporation | 4 | $96 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $55 |
| Novartis | 3 | $47 |
| Zimmer Biomet | 1 | $47 |
| Antares Pharma, Inc. | 2 | $44 |
| Exact Sciences | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Boehringer Ingelheim | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Vistapharm, Inc. | 1 | $14 |
| Reel Surgical, Inc. | 1 | $13 |
| Merck | 1 | $13 |
How this compares
$1,962 in reported general payments places this provider in the 50th percentile of 402 sports medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 37 | $250 |
| Amlodipine Besylate | 17 | $172 |
| Meloxicam | 59 | $157 |
| Lisinopril | 23 | $94 |
| Levothyroxine Sodium | 13 | $83 |
| Prednisone | 19 | $35 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Orlando
- Bruce LevyOrlando$816K
- Andrew CarboneOrlando$90K
- Abhishek KannanOrlando$33K
- Kyle CoxOrlando$29K
- Callie JewettOrlando$23K
- Lee KaplanMiami$11.3M
- Patrick SmithNaples$2.9M
- Ryan SimovitchWest Palm Beach$1.1M
- Gautam YagnikMiami$440K
- Carl DilellaVero Beach$384K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.